SCHEMBL2490613

SCHEMBL2490613

CCC(=O)C(N)C(=O)OCc1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.53
SLC15A1 P46059 2/20 0.48
KMT2A Q03164 3/20 0.47
L3MBTL1 Q9Y468 3/20 0.47
MAPK1 P28482 2/20 0.47
TDP1 Q9NUW8 2/20 0.47
SLC6A2 P23975 1/20 0.47
SLC6A3 Q01959 1/20 0.47
LTA4H P09960 1/20 0.46
LAP3 P28838 1/20 0.46
SLC1A3 P43003 2/20 0.45
SLC1A2 P43004 2/20 0.45
SLC1A1 P43005 2/20 0.45
MEN1 O00255 1/20 0.45
CYP1A2 P05177 1/20 0.45
CYP2D6 P10635 1/20 0.45
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45
RAB9A P51151 3/20 0.44
GAA P10253 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL2490609 0.98 ALDH1A1 (0.51) ALDH1A1SLC15A1KMT2AL3MBTL1MAPK1
SCHEMBL7694383 0.86 ALDH1A1 (0.59) ALDH1A1SLC15A1KMT2AL3MBTL1MAPK1
SCHEMBL3231535 0.85 ALDH1A1 (0.55) ALDH1A1SLC15A1KMT2AL3MBTL1MAPK1
SCHEMBL9852770 0.83 ALDH1A1 (0.49) ALDH1A1SLC15A1KMT2AL3MBTL1MAPK1
Hydrochloric Acid SCHEMBL27925213 0.83 ALDH1A1 (0.53) ALDH1A1SLC15A1KMT2AL3MBTL1MAPK1
SCHEMBL9081027 0.83 ALDH1A1 (0.61) ALDH1A1SLC15A1KMT2AL3MBTL1MAPK1
SCHEMBL9082362 0.83 ALDH1A1 (0.61) ALDH1A1SLC15A1KMT2AL3MBTL1MAPK1
SCHEMBL4788226 0.82 ALDH1A1 (0.55) ALDH1A1SLC15A1KMT2AL3MBTL1MAPK1
Hydrochloric Acid SCHEMBL9081023 0.81 ALDH1A1 (0.59) ALDH1A1SLC15A1KMT2AL3MBTL1MAPK1
SCHEMBL7424592 0.81 ALDH1A1 (0.55) ALDH1A1KMT2AL3MBTL1MAPK1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8211914-B2 Inhibitors of diacylglycerol acyltransferase MADRIGAL PHARMACEUTICALS, INC. (US) 2012-07-03 US disclosed
EP-2378878-A1 INHIBITORS OF DIACYLGLYCEROL ACYLTRANSFERASE Via Pharmaceuticals, Inc. (US) 2011-10-26 EP disclosed
WO-2010077861-A1 INHIBITORS OF DIACYLGLYCEROL ACLYTRANSFERASE VIA PHARMACEUTICALS, INC (US) 2010-07-08 WO disclosed
US-20100152445-A1 Inhibitors of Diacylglycerol Acyltransferase MADRIGAL PHARMACEUTICALS, INC. 2010-06-17 US disclosed
CN-1160343-C Aminothiazole inhibitors of cyclin dependent protein kinasses of cells ����˹�ж�-����˹˹������˾ 2004-08-04 CN disclosed
CN-1433408-A Aminothiazole inhibitors of cyslin dependent kinases BRISTOL MYERS SQUIBB CO (US) 2003-07-30 CN disclosed
CN-1278806-A Aminothiazole inhibitors of cyclin dependent protein kinasses of cells BRISTOL MYERS SQUIBB CO (US) 2001-01-03 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100152445-A1 Inhibitors of Diacylglycerol Acyltransferase DGAT2, DGAT1, ACAT2 ALDH1A1 1249/4885SLC15A1 3352/4885KMT2A 845/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.